Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
Trackers› Clinical trials› South Brisbane
Clinical trial register · Australia

Clinical Trials in South Brisbane, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Australia and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 3343 matching records held by the registry are in this view. Synced 15 Oct 2026, 03:18 UTC
3343
Studies in scope
all four open statuses
1804
Recruiting now
open to new participants
765
Lead sponsors
across recruiting studies
Top sites
Melbourne 37 Clayton 21 Murdoch 20 Camperdown 17 Heidelberg 16
Narrow the registerReset
Recruitment status
Phase
Site location
Melbourne37 Clayton21 Murdoch20 Camperdown17 Heidelberg16
All 73 locations
Target enrolment
to

Trials with a site in South Brisbane

11 of 3343 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Australia
Start
Recruiting
A Study on Hemolytic Disease of the Fetus and Newborn (HDFN) Through Global Registry
NCT07194070Hemolytic Disease of the Fetus and Newborn
Janssen Research & Development, LLC
Observational
175
Parkville, South Brisbane
2025-12-17
Recruiting
Janssen Research & Development, LLC
Phase 2/3
1,092
Clayton, Concord, Fitzroy, Murdoch, New Lambton Heights, South Brisbane
2025-10-03
Recruiting
Janssen Research & Development, LLC
Phase 3
882
Clayton, Concord, Fitzroy, Murdoch, New Lambton Heights, Parkville, South Brisbane
2025-10-01
Recruiting
A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
NCT06663332Crohns Disease, Colitis, Ulcerative, Arthritis, Psoriatic, Arthritis, Juvenile
Janssen Research & Development, LLC
Phase 3
196
Nedlands, South Brisbane, Westmead
2024-10-29
Recruiting
Janssen Research & Development, LLC
Phase 3
120
Nedlands, South Brisbane, Westmead
2024-03-13
Active, closed
Janssen Research & Development, LLC
Phase 3
112
Nedlands, South Brisbane, Westmead
2024-01-19
Recruiting
Janssen Research & Development, LLC
Phase 3
120
South Brisbane, Sydney
2023-12-20
Active, closed
Janssen Research & Development, LLC
Phase 3
420
Macquarie University, Melbourne, South Brisbane
2023-08-31
Active, closed
Janssen Research & Development, LLC
Phase 3
1,135
Heidelberg, Macquarie University, Nedlands, South Brisbane
2023-03-23
Active, closed
Janssen Research & Development, LLC
Phase 3
418
Adelaide, Camperdown, Clayton, Herston, Murdoch, Parkville, South Brisbane, Woodville South
2022-09-13
Active, closed
Janssen Research & Development, LLC
Phase 2/3
1,064
Camberwell, Clayton, Footscray, Murdoch, Perth, South Brisbane, Subiaco, Woolloongabba
2019-09-26
Rows per page Showing 1–11 of 11
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Australian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 15 October 2026. https://priyalifescience.com/clinical-trials-australia/city/south-brisbane

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Australia and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 3,343 studies in total at the last sync on 15 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 11 of those studies with a site in South Brisbane that also match the filters currently applied.

How many clinical trials are recruiting in South Brisbane?

6 of the 11 studies on this page are recruiting new participants as of the 15 Oct 2026, 03:18 UTC sync. A further 0 have not yet opened recruitment, 5 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (South Brisbane), 11 studies
PhaseStudiesRecruitingShare
Phase 38472.7%
Phase 2/32118.2%
Observational119.1%

Most active sponsors

Lead sponsors with the most studies (South Brisbane)
Lead sponsorStudiesRecruiting
Janssen Research & Development, LLC116
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.